Dublin biotech Aerska launches with €17.8M Seed round to tackle Alzheimer’s and Parkinson’s
Dublin-based Aerska, a biotechnology company specialising in the treatment of neurological diseases, announced its launch along with $21M (approximately €17.8M) ...
